AU2002356423A1 - Process for the preparation of amorphous atorvastatin calcium - Google Patents
Process for the preparation of amorphous atorvastatin calciumInfo
- Publication number
- AU2002356423A1 AU2002356423A1 AU2002356423A AU2002356423A AU2002356423A1 AU 2002356423 A1 AU2002356423 A1 AU 2002356423A1 AU 2002356423 A AU2002356423 A AU 2002356423A AU 2002356423 A AU2002356423 A AU 2002356423A AU 2002356423 A1 AU2002356423 A1 AU 2002356423A1
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- atorvastatin calcium
- amorphous atorvastatin
- amorphous
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- OJRHUICOVVSGSY-RXMQYKEDSA-N (2s)-2-chloro-3-methylbutan-1-ol Chemical compound CC(C)[C@H](Cl)CO OJRHUICOVVSGSY-RXMQYKEDSA-N 0.000 title 1
- 229960001770 atorvastatin calcium Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN472/MUM/2002 | 2002-05-28 | ||
| IN472MU2002 | 2002-05-28 | ||
| PCT/IN2002/000220 WO2003099785A1 (en) | 2002-05-28 | 2002-11-15 | Process for the preparation of amorphous atorvastatin calcium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002356423A1 true AU2002356423A1 (en) | 2003-12-12 |
Family
ID=29560492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002356423A Abandoned AU2002356423A1 (en) | 2002-05-28 | 2002-11-15 | Process for the preparation of amorphous atorvastatin calcium |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002356423A1 (en) |
| PL (1) | PL357490A1 (en) |
| WO (1) | WO2003099785A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL156055A0 (en) * | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
| AU2004317570B2 (en) | 2004-03-17 | 2011-01-06 | Ranbaxy Laboratories Limited | Process for the production of atorvastatin calcium in amorphous form |
| WO2006012499A2 (en) * | 2004-07-22 | 2006-02-02 | Teva Pharmaceutical Industries Ltd. | Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| WO2006021969A1 (en) * | 2004-08-27 | 2006-03-02 | Biocon Limited | Process for atorvastatin calcium amorphous |
| ES2272206T1 (en) | 2004-10-18 | 2007-05-01 | Teva Pharmaceutical Industries Ltd. | PROCEDURE FOR THE PREPARATION OF HEMICALCID ATORVASTATIN AMORPHY BY DISSOLVING SALT IN AN ORGANIC SOLVENT WHICH IS A MIXTURE OF A SPIRIT, AND A KETONE AND / OR AN ESTER AND ELIMINATION OF THE SOLVENT. |
| EP2075246A1 (en) | 2007-12-27 | 2009-07-01 | M. J. Institute of Research | A process for preparation of amorphous form of atorvastatin hemi-calcium salt |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP960312B1 (en) * | 1995-07-17 | 2001-10-31 | Warner Lambert Co | NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS /R-(R*, R*)/-2-(4-FLUOROPHENYL)-"beta", "delta"-DIHYDROXY-5-PHENYL-4-/(PHENYLAMINO)CARBONYL/-1H-PYRROLE -1-HEPTANOIC ACID CALCIUM SALT (2 : 1) |
| IN191236B (en) * | 1999-05-25 | 2003-10-11 | Ranbaxy Lab Ltd | |
| HU226640B1 (en) * | 1999-10-18 | 2009-05-28 | Egis Gyogyszergyar Nyilvanosan | Process for producing amorphous atorvastatin calcium salt |
| SI20425A (en) * | 1999-12-10 | 2001-06-30 | LEK tovarna farmacevtskih in kemi�nih izdelkov d.d. | Preparation of amorphous atorvastatin |
| IL156055A0 (en) * | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
-
2002
- 2002-11-15 AU AU2002356423A patent/AU2002356423A1/en not_active Abandoned
- 2002-11-15 WO PCT/IN2002/000220 patent/WO2003099785A1/en not_active Ceased
- 2002-12-02 PL PL02357490A patent/PL357490A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003099785A1 (en) | 2003-12-04 |
| PL357490A1 (en) | 2003-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002332638A1 (en) | Method for the preparation of crystalline tetrahydrobenzothiepines | |
| EP1546122B8 (en) | Process for the manufacture of valsartan | |
| IL159626A0 (en) | Crystalline forms of atorvastatin calcium and processes for the preparation thereof | |
| AU2001284385A1 (en) | An improved process for the preparation of amorphous atorvastatin calcium salt (2:1) | |
| AU2002307805A1 (en) | Process for the preparation of cefdinir | |
| PL368984A1 (en) | Process for the preparation of crystalline imipenem | |
| HUP0300761A3 (en) | Process for the production of amorphous atorvastatin calcium | |
| AU2003260983A1 (en) | Processes for the preparation of s-(-)-amlodipine | |
| AU2002356423A1 (en) | Process for the preparation of amorphous atorvastatin calcium | |
| AU2002367890A1 (en) | Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate | |
| AU2003245880A1 (en) | Process for the preparation of thioalkylamine derivatives | |
| AU2003260078A1 (en) | Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof | |
| AU2003269478A1 (en) | A novel process for amorphous rosuvastatin calcium | |
| AU2002359034A1 (en) | Process for the preparation of simvastatin | |
| AU2003217438A1 (en) | Novel crystalline forms of levetiracetam | |
| AU2003247327A1 (en) | Process for the preparation of amortphous atorvastatin calcium without interconversion of any crystalline form | |
| IL150907A0 (en) | Stable amorphous calcium pseudomonate and process for the preparation thereof | |
| AU2002337601A1 (en) | Process for the preparation of simvastatin | |
| AU2003229181A1 (en) | Stable dosage forms comprising atorvastatin calcium | |
| AU2003243432A1 (en) | Process of making phosphordiamidite compounds | |
| AU2001278668A1 (en) | Process for the production of amorphous atorvastatin calcium | |
| AU2003272082A1 (en) | Process for the production of atorvastatin calcium | |
| EP1386911A3 (en) | Process for the preparation of acyloxybenzenesulfonates | |
| AU2003223104A1 (en) | A process for the preparation of indolymaleimides | |
| AU2001280083A1 (en) | Process for the production of atorvastatin calcium in amorphous form |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |